|
|
2004-present
The reports that feature these Executive Summaries are published and available for immediate shipment.
The PI3K/Akt/mTOR Pathway
November 2011
New Trends in Preventive and Therapeutic Vaccines
October 2011
Cytokine-Based Therapies and Inhibitors:R&D Pipelines, Markets, and Strategic Issues
September 2011
Kinase-Targeted Therapeutics
August 2011
Next Generation Mass Spectrometry
July 2011
Commercializing Biomarkers in Therapeutic and Diagnostic Applications
May 2011
Advanced Drug Delivery Technologies
January 2011
Next-Generation Sequencing Technologies: Applications and Markets
October 2010
Nuclear Receptors: The Pipeline Outlook
September 2010
Therapeutic Protein Production: A Changing Landscape
July 2010
Epigenetic Drug & Diagnostic Pipelines
June 2010
Combination Drug/Diagnostics: Fueling Growth of Personalized Medicine
April 2010
Animal Models for Therapeutic Strategies
March 2010
Kinase Therapeutics: Pipeline Assessment and Commercial Prospects
January 2010
Multiplex Assays: Evolving Technologies, Applications and Future Directions
January 2010
Strategic Alliances: Synergistic Path to Value Creation
January 2010
Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response
December 2009
Immunotherapies and Vaccines for Nontraditional Indications
October 2009
Ion Channel Modulator Pipelines
September 2009
Monoclonal Antibodies: Pipeline Analysis and Competitive Assessment
August 2009
Outsourcing Preclinical Studies to China
July 2009
Data Mining in Drug Development and Translational Medicine
July 2009
Next-Generation Sequencing: Solving the Genome
June 2009
Pharmacogenomics: Delivering on the Promise
June 2009
Bioinformatics and Computational Biology: Bottlenecks and Options
June 2009
Approaches to Reducing Phase II Attrition
May 2009
Direct-To-Consumer Genetic Testing: Business Prospects in the United States
March 2009
Medicinal Chemistry for Drug Discovery: Significance of Recent Trends
March 2009
Protease Inhibitors: Innovation Drives Drug Pipeline
February 2009
Molecular Diagnostics: A Dynamic and Rapidly Broadening Market
January 2009
Biomedical Imaging: From Drug Target Discovery to Medical Diagnostics
December 2008
Neurodegenerative Diseases: Next-Generation Drugs for Four Major Disorders
December 2008
Conducting Clinical Trials in Europe: An Insider's Analysis
December 2008
Immunotherapies and Vaccines for Cancer and Infectious Diseases
October 2008
GPCRs: Dawn of a New Era?
October 2008
Obesity Drug Pipeline: Developing Therapies for a Complex Disease
September 2008
Strategic Management of Resources and Portfolios
August 2008
Cancer Biomarkers: Adoption Is Driving Growth
July 2008
Antibiotic R&D: Resolving the Paradox between Unmet Medical Need and Commercial Incentive
July 2008
Systems Biology: A Disruptive Technology
May 2008
Blood-Brain Barrier: Bridging Options for Drug Discovery & Development
May 2008
Cardiotoxicity: Issues, Technologies, and Solutions for the Future
May 2008
Inflammatory Directions: Strategies for Six Diseases with Unmet Needs
April 2008
MicroRNAs: Commercial Products on the Horizon
March 2008
Epigenetics: Technologies, Applications, and the Commercial Landscape
February 2008
Multiplex Assays in Translational Medicine: Technologies, Applications, and Future Directions
February 2008
Molecular Imaging in Drug R&D and Medical Practice
January 2008
Ophthalmological Therapeutics: Pipelines, Delivery Technologies, and Markets
January 2008
Kinase Therapeutic Pipelines: An Assessment of Targets and Agents in Development
December 2007
Molecular Diagnostics: A Rapidly Shifting Commercial and Technology Landscape
November 2007
Monoclonal Antibodies: Pipeline Analysis and Market Assessment
October 2007
Backup Compound Strategies: Best Practices for Reducing Phase II Risk
September 2007
Adaptive Clinical Trials: Innovation in Trial Design, Management, and Analysis
September 2007
Next-Generation Sequencing: Scientific and Commercial Implications of the $1000 Genome
August 2007
Clinical Forecasting: A Novel Bayesian Tool for Predicting Phase III Outcomes
July 2007
Disease-Related Biomarkers: Their Potential in Patient Screening, Prognosis, and Stratification
June 2007
Diabetes and Its Complications: Strategies to Advance Therapy and Optimize R&D
May 2007
High-Content Analysis: Technologies, Applications, Market Analysis
May 2007
Combination Drug/Diagnostic Products: Pathways to R&D and Commercial Success
May 2007
Metabolic and Inflammatory Disease R&D : An Assessment of 5 Highly Promising Therapeutic Classes
April 2007
Delivery Technologies for Therapeutic Proteins: Assessment and Outlook
March 2007
Cytokine Therapeutics: A Vibrant Pipeline and Active Approved Market
February 2007
Biomarker SOPs: Getting Optimum Value from Your Biomarker Program
January 2007
Outlook for Predictive Safety Technologies
November 2006
Cancer Immunotherapies and Vaccines: Pipeline Analysis and Competitive Dynamics
November 2006
Specialty Pharmaceuticals: Driving Industry Growth into the Next Decade
October 2006
Potential Breakthroughs in Neurotherapeutics: Alzheimer's Disease, Parkinson's Disease, Depression, Bipolar Disorder, and Schizophrenia
October 2006
Infectious Diseases: R&D Challenges and Market Drivers
September 2006
Comparative Genomic Hybridization: Current State and Future Directions
September 2006
Proteomics: Current State and Future Directions
September 2006
Antiviral Therapeutics: Pipelines and Competitive Dynamics
July 2006
Emerging Targets in Diseases with High Unmet Need: Alzheimer's Disease, Lung Cancer, Dyslipidemia, Type 2 Diabetes, and COPD
June 2006
Microdosing in Translational Medicine: Pros and Cons
May 2006
Kinase Therapeutics: A Wealth of Targets Sparks a Highly Active Market
May 2006
The Impact of Genomics on Clinical Trials and Medical Practice
April 2006
Multiplex Assays: Technologies, Applications, and Markets
April 2006
Oncogenomics: The Future of Cancer Cure
January 2006
Molecular Diagnostics: New Growth, New Markets
November 2005
RNAi Therapeutics: Challenges in Drug Development and Delivery
November 2005
A New Paradigm for Clinical Development: The Clinical Trial in 2015
November 2005
Hematological Cancer Therapeutics: Pipelines and Competition
October 2005
Cancer Diagnostics: Technology and Business Trends
October 2005
Pharmaceutical R&D Productivity: The Path to Innovation
October 2005
Combination Therapies: Benefits and Challenges in Drug, Device, and Biologicals Development
August 2005
Powering Discovery through Target Evaluation: Moving Beyond the Validation Paradigm
August 2005
Pharmacodiagnostics: Technologies: Technologies, Competition, and Market Models
July 2005
Nutrigenomics: Impacts on Markets
June 2005
Inflammatory Disease Therapeutics: Pipelines
June 2005
Cardiovascular Diagnostics: Key Developments in Technologies and Markets
May 2005
Biomarkers in Clinical Development: Implications for Personalized Medicine and Streamlining R&D
March 2005
Neurogenomics and Neurotherapeutic Strategies: New Directions in Platforms, Targets, and Therapeutic Approaches
March 2005
2015: Strategic Considerations for the US Pharmaceutical Industry
February 2005
Metabolic Syndrome: Pipeline Analysis/Forecast
January 2005
|
|
|